Mokobio™ Biotechnology is a global biotechnology company focused on developing the next-generation innovative platform that enables reliable Genomic Testing and Personalized Therapeutics to promote the health of public across the world.
WHAT WE DO
At Mokobio™ Biotechnology, we focus on developing the next-generation platform that enables reliable in vitro diagnostic (IVD) tests to promote the health of public across the world. We specialize in developing molecular diagnostic assay in the field of Point of Care Test (POCT) and precision medicine. To find out how our scientist team continues to develop new ways fighting Covid-19, check out our newly series of products including SARS-CoV-2 Quantum Dot Immunoassay Test and Colloidal Gold Assay Test.